FDA Warns About Compounded Versions of Ozempic and Wegovy
XTalks
JUNE 5, 2023
Ozempic and Wegovy, which contain the active ingredient semaglutide, were approved by the US Food and Drug Administration (FDA). As of May 2023, both Ozempic and Wegovy were on the FDA’s Drug Shortages list due to a global shortage of semaglutide. The approved drugs contain the base form of semaglutide.
Let's personalize your content